JAK-STAT signaling as an ARDS therapeutic target: Status and future trends
Y Zhang, Z Gao, F Jiang, H Yan, B Yang, Q He… - Biochemical …, 2023 - Elsevier
Acute respiratory distress syndrome (ARDS) is characterized by noncardiogenic pulmonary
edema. It has a high mortality rate and lacks effective pharmacotherapy. With the outbreak of …
edema. It has a high mortality rate and lacks effective pharmacotherapy. With the outbreak of …
JAK-STAT signaling as an ARDS therapeutic target: status and future trends
Y Zhang, Z Gao, H Yan, B Yang, Q He, P Luo… - Authorea …, 2022 - essopenarchive.org
Acute respiratory distress syndrome (ARDS) is an acute respiratory disease which is
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
JAK-STAT signaling as an ARDS therapeutic target: status and future trends
Y Zhang, Z Gao, H Yan, B Yang, Q He… - Authorea …, 2022 - advance.sagepub.com
Acute respiratory distress syndrome (ARDS) is an acute respiratory disease which is
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
JAK-STAT signaling as an ARDS therapeutic target: Status and future trends
Y Zhang, Z Gao, F Jiang, H Yan… - Biochemical …, 2023 - pubmed.ncbi.nlm.nih.gov
Acute respiratory distress syndrome (ARDS) is characterized by noncardiogenic pulmonary
edema. It has a high mortality rate and lacks effective pharmacotherapy. With the outbreak of …
edema. It has a high mortality rate and lacks effective pharmacotherapy. With the outbreak of …
JAK-STAT signaling as an ARDS therapeutic target: status and future trends
Y Zhang, Z Gao, H Yan, B Yang, Q He, P Luo… - Authorea …, 2022 - authorea.com
Acute respiratory distress syndrome (ARDS) is an acute respiratory disease which is
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
JAK-STAT signaling as an ARDS therapeutic target: status and future trends
Y Zhang, Z Gao, H Yan, B Yang, Q He, P Luo, Z Xu… - Authorea …, 2022 - techrxiv.org
Acute respiratory distress syndrome (ARDS) is an acute respiratory disease which is
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
JAK-STAT signaling as an ARDS therapeutic target: Status and future trends.
Y Zhang, Z Gao, F Jiang, H Yan, B Yang… - Biochemical …, 2022 - europepmc.org
Acute respiratory distress syndrome (ARDS) is characterized by noncardiogenic pulmonary
edema. It has a high mortality rate and lacks effective pharmacotherapy. With the outbreak of …
edema. It has a high mortality rate and lacks effective pharmacotherapy. With the outbreak of …
JAK-STAT signaling as an ARDS therapeutic target: status and future trends
Y Zhang, Z Gao, H Yan, B Yang, Q He, P Luo, Z Xu… - 2022 - europepmc.org
Acute respiratory distress syndrome (ARDS) is an acute respiratory disease which is
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
JAK-STAT signaling as an ARDS therapeutic target: status and future trends
Y Zhang, Z Gao, H Yan, B Yang, Q He, P Luo, Z Xu… - 2022 - advance.sagepub.com
Acute respiratory distress syndrome (ARDS) is an acute respiratory disease which is
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …
characterized by non-cardiogenic pulmonary oedema. It has a high mortality rate and lacks …